The sheer scale of undiagnosed heart valve disease in our ageing population has been revealed for the first time, thanks to new research led by the University of East Anglia.
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering – Biotech Investments
Siegfried AG / Key word(s): Acquisition 12-Jun-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely